Acute Lymphoblastic Leukemia ALL Clinical Trials

14 recruiting

Frequently Asked Questions

Common questions about Acute Lymphoblastic Leukemia ALL clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 114 of 14 trials

Recruiting
Phase 2

International Study for Treatment of High Risk Childhood Relapsed ALL 2010

Acute Lymphoblastic Leukemia ALL
Charite University, Berlin, Germany250 enrolled15 locationsNCT03590171
Recruiting
Not Applicable

Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic Leukemia

InsomniaAcute Lymphoblastic Leukemia ALLSurvivor of Childhood Cancer
St. Jude Children's Research Hospital40 enrolled1 locationNCT07191119
Recruiting

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Hodgkin LymphomaNon-Hodgkin LymphomaHematologic Malignancies+14 more
Center for International Blood and Marrow Transplant Research99,999 enrolled142 locationsNCT01351545
Recruiting
Not Applicable

Children's Laughter and Fun Yoga as Adjunctive Pain Relief Following Chemotherapy.

Acute Lymphoblastic Leukemia ALL
Bahaa Bou Dargham60 enrolled1 locationNCT07327138
Recruiting

Tracjectories and Predictors of Chemotherapy Induced Peripheral Neuropathy in Children With Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia ALL
The Hong Kong Polytechnic University173 enrolled3 locationsNCT07326930
Recruiting

CAYA Cancer Retrospective Cohort Study

Acute Lymphoblastic LeukemiaLymphoblastic LymphomaAcute Lymphoblastic Leukemia ALL+4 more
Resonance, Inc.18,000 enrolled5 locationsNCT07246213
Recruiting

Bio-CAR-T BS Study

Diffuse Large B-Cell Lymphoma (DLBCL)Acute Lymphoblastic Leukemia ALLPrimary Mediastinal Large B-cell Lymphoma (PMBCL)
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia45 enrolled1 locationNCT05366569
Recruiting
Phase 2

Cord Blood Transplant in Adults With Blood Cancers

Non-Hodgkin's LymphomaAcute Myelogenous Leukemia (AML)Myelodysplastic Syndromes (MDS)+3 more
Memorial Sloan Kettering Cancer Center54 enrolled1 locationNCT05884333
Recruiting
Phase 2Phase 3

Newly-diagnosed Low Risk Pediatric B-cell ALL Protocol

Childhood Leukemia, Acute LymphoblasticB-cell Acute Lymphoblastic Leukemia (B-ALL)Acute Lymphoblastic Leukemia ALL
Institute of Hematology & Blood Diseases Hospital, China3,000 enrolled27 locationsNCT06882057
Recruiting
Not Applicable

Safely Delivered Targeted High-dose Irradiation Followed by Adoptive Immunotherapy with Regulatory and Conventional T Cells to Increase Potency of Hematopoietic Stem Cell Transplantation in High-risk Acute Leukemia

Acute Lymphoblastic Leukemia ALLAcute Myeloid Leukaemia (AML)High Risk Leukaemia+1 more
University Of Perugia51 enrolled1 locationNCT06845592
Recruiting
Phase 2Phase 3

Newly-diagnosed Intermediate/High Risk Pediatric B-cell ALL Protocol

Childhood Leukemia, Acute LymphoblasticB-cell Acute Lymphoblastic Leukemia (B-ALL)Acute Lymphoblastic Leukemia ALL
Institute of Hematology & Blood Diseases Hospital, China1,800 enrolled26 locationsNCT06764238
Recruiting
Not Applicable

Bright Ideas - CIN Feasibility Study

Acute Lymphoblastic Leukemia ALL
The Hospital for Sick Children75 enrolled4 locationsNCT04929899
Recruiting
Phase 2

Autologous Hematopoietic Stem Cell Transplantation Combined With CD19-CART Treatment of Adult High-risk Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia ALL
Institute of Hematology & Blood Diseases Hospital, China20 enrolled1 locationNCT06608342
Recruiting
Phase 1

CAR T Cells in the Treatment of Refractory and Relapsed CD19+ B Cell Neoplasms

Acute Lymphoblastic Leukemia ALLLarge B-cell LymphomaMantle Cell Lymphoma (MCL)
FamiCordTx6 enrolled2 locationsNCT06593145